Scientists identify chimeric RNA molecules as essential in cellular health and disease, finding they play a wide variety of critical roles in vital cellular processes. Faulty chimeric RNA are often malfunctioning in breast cancer tumors, prompting new cancer treatments targeting specific chimeras.
The American Society of Hematology has developed new reference ranges for children and adults with Duffy-null status, a common genetic trait associated with lower circulating white blood cell counts. These personalized ranges will help clinicians accurately determine normal and abnormal white blood cell counts, preventing unnecessary t...
A research team identified a signaling pathway involving AQP4, TRPA1, BEST1, and D-serine that helps maintain neuronal activity and cerebral blood-volume responses during prolonged sensory stimulation. Astrocytes release D-serine, which supports neuronal activity and contributes to dilation of brain blood vessels.
Researchers identified lysophosphatidylcholine (LPC) as a key metabolic mediator of macrophage dysfunction in immune thrombocytopenia. A two-drug combination of dexamethasone and atorvastatin restores immune balance and reverses platelet count recovery.
A targeted immunoPET scan detected active multiple myeloma that standard PET/CT scans and blood tests missed, revealing active disease in patients with no signs of cancer. The scan, which uses labeled antibodies to recognize myeloma-specific surface proteins, showed promising results in a phase 2 clinical trial.
A new study has found that combining medications dobutamine and norepinephrine during septic shock surgery can significantly lower the risk of acute kidney injury. The trial, which tracked 584 adult patients, showed that the drug combination cut the risk of severe kidney damage in half, reducing moderate to severe kidney injuries.
Carsten Bönnemann, MD, habil., was elected to the National Academy of Medicine for his research on neuromuscular disorders and his work advancing novel therapeutics. As the inaugural chair of St. Jude's Department of Genomic and Translational Neuroscience, Bönnemann aims to address the unmet need for effective treatments for progressiv...
The American Society of Hematology has released new guidelines for managing myelofibrosis, a rare and life-threatening blood cancer. The guidelines recommend expanded molecular testing, early transplant referral, and appropriate use of JAK inhibitors to improve patient care and outcomes.
A study published in the Journal of Alzheimer's Disease found that people with low or high haemoglobin levels had a higher risk of developing dementia over a 15-year period. The research suggests that abnormal haemoglobin levels may be a marker of physical vulnerability relevant to brain health.
NCCN has published regional cancer treatment guidelines for the Philippines, tailored to the local setting and regulatory environment. The guidelines reflect collaborations with global organizations, including the International Gynecologic Cancer Society and the Philippine Society of Medical Oncology, to improve access to high-quality ...
Researchers are working on a four-year project to develop a personalized model that uses detailed blood flow information to detect obstructions in the aorta. The project aims to improve prenatal testing so that doctors can spot problems in the aorta before a baby is born and recommend treatments.
The grant will support research experiences for 12 WPI undergraduates in Solomon Mensah's lab, aiming to determine the molecular mechanisms behind sepsis-induced blood clotting. The goal is to rescue a damaged glycocalyx barrier, paving the way for sepsis treatments.
A phase 2 trial found that vitamin C may benefit people with pre-cancer blood disorders by altering inflammatory signaling molecules and reducing adverse events. The study suggests that vitamin C may help regulate inflammatory pathways associated with growth and progression of pre-cancerous blood cells.
Dr. Mark Walker led a seminar on pre-eclampsia, a condition that affects 2-4% of pregnancies and can be life-threatening. The seminar reviews current knowledge, strategies for prevention, and highlights a critical global health challenge, particularly in low-income and middle-income countries.
Iron deficiency affects an estimated 10 million adults in the US and 2 billion people worldwide, with up to 70% of cases missed among high-risk populations. ASH's new guidelines provide higher ferritin thresholds to help clinicians identify iron deficiency earlier and more accurately.
Complimentary press passes are now available for the Association for Molecular Pathology 2026 Annual Meeting & Expo in Seattle, featuring over 200 exhibiting companies, 60 educational sessions, and 500 poster presentations. Reporters can register to attend in person or access press materials online.
Researchers analyzed data from the Framingham Heart Study to investigate the relationship between menopause and aortic stiffness. The study found that factors other than menopause timing contributed to the increase in pulse pressure in women after midlife.
The 2026 Josep Carreras Institute Symposium explores the latest immunology advances in haematological malignancies, transforming treatment landscapes with CAR-T therapies and checkpoints. Major challenges remain in understanding tumour-immune system interactions and therapeutic resistance.
Advances in blood cancer treatment have saved 25.8 million life-years, with significant gains for Hodgkin lymphoma and non-Hodgkin lymphoma patients. However, Black patients and those with acute myeloid leukemia (AML) continue to experience worse outcomes, highlighting the need for continued research investment.
A prospective multicenter study found the EAP regimen delivered outstanding mobilization effects, achieving 90.8% optimal mobilization in patients. The regimen showed good clinical tolerability, with most hematological toxicities well managed, and presented a practical alternative to conventional mobilization strategies.
Dr. Georg Aue, a nationally recognized blood cancer expert, has been named the inaugural director of the Stem Cell Transplant and Cellular Therapy Program at UT Health San Antonio. The program aims to increase access to new therapeutic approaches for patients across South Texas, with a focus on clinical excellence, research innovation,...
Matthew Gertzog has been named the American Society of Hematology's next lead staff executive and chief executive officer, succeeding Martha Liggett after 30 years. Gertzog brings nearly 40 years of experience in nonprofit and association management to the role.
A Japan-wide study found that growth hormone therapy improves adult height in childhood stem cell transplant survivors with short stature. However, treatment responses were highly variable and influenced by transplant-related factors such as total body irradiation and chronic graft-versus-host disease.
The Alliance QUANTUM trial is testing whether post-transplant consolidation therapy with teclistamab improves survival in patients with primary plasma cell leukemia. Plasma cell leukemia is a rare but aggressive blood cancer with poor long-term survival rates.
A new study found that a simple blood test can accurately identify tuberculosis (TB) among patients, which could help save millions of lives and reduce transmission. The test measures a specific marker called ESAT-6 produced by the TB bacteria.
A new global report highlights opportunities to strengthen diagnosis, treatment, and education for women and girls with hematological conditions. The report calls for earlier diagnosis, more consistent treatment, and stronger research and education to improve outcomes globally.
A novel therapy targeting the bone marrow microenvironment is shown to accelerate recovery and promote hematopoietic regeneration after injury. Pharmacological activation of YAP/TAZ improves BM niche recovery, enhancing engraftment and white blood cell recovery following HSCT.
Researchers have successfully produced genome-edited T cells that can target and destroy cancer cells using the Platinum TALEN genetic engineering technique. The technique was found to be efficient, with an average yield of 72 million 1G4-TCR cells for every 3 million T-cells.
ASH recognizes 11 leaders in hematology, including Elliott Vichinsky and Leon Bernal-Mizrachi, for transformative contributions to patient care and research. The awards highlight their dedication to improving outcomes and addressing health disparities.
A study by Wake Forest University School of Medicine found nearly one in five caregivers reported experiencing food insecurity during their child's hospital stay. Children whose caregivers faced food insecurity stayed in the hospital about a third longer on average, with higher rates of readmission within 30 days.
Dr. Josep Maria Ribera receives the EHA Clinical Excellence Award for his distinguished career in Acute Lymphoblastic Leukaemia treatment and patient care improvements. He is also recognized for his academic mentorship, training numerous haematologists who now lead positions in the field.
A new study by the American Society of Hematology finds that stem cell transplantation is the most cost-effective option for long-term care of sickle cell disease in adults. Gene therapy, while promising, comes with an astronomical cost and requires a significant price reduction to be competitive.
Researchers found that iron deficiency may be more common and diagnosable earlier in U.S. school-aged children using a new method, detecting early stages of iron deficiency by looking at changes in red blood cells.
A study by Osaka Metropolitan University found that women with a higher proportion of LOX cells in their white blood cells had a lower likelihood of achieving natural pregnancy. The researchers suggest combining AMH analysis with LOX measurement may improve prediction of natural conception.
A research team at the University of Cologne discovered that the protein cFLIP can be used to override the defences of Diffuse Large B Cell Lymphoma (DLBCL) against programmed cell death. Targeting cFLIP could re-activate cell death in lymphoma cells and provide a new therapy option.
Sickle cell disease affects an estimated 7.74 million people worldwide, with sub-Saharan Africa accounting for two-thirds of global cases. Individuals living in this region are less likely to use medications or go to the hospital for pain crises, relying more on homeopathic remedies and delaying medical care.
The American Society of Hematology and the International Society on Thrombosis and Haemostasis have released comprehensive guidelines for anticoagulant prophylaxis in non-cardiac pediatric patients at risk of venous thromboembolism. The guidelines outline best practices for preventing life-threatening complications in children.
The ASH HematOmics Program platform combines genomics, gene expression, and clinical information from nearly 6,000 patients with blood cancers. Researchers can explore these datasets together in a single open resource, accelerating discovery in hematological malignancies.
A team of researchers at North Carolina State University has created an injectable microgel called B-knob triggered microgels (BK-TriGs) that can help reduce bleeding in infants during surgery. The microgel works by mimicking the mechanical properties of natural platelets, which helps to create fibrin networks and stanch bleeding.
The American Society of Hematology has published clinical practice guidelines for diagnosing and managing severe acquired aplastic anemia, a rare and life-threatening bone marrow failure disorder. The guidelines highlight the importance of shared decision-making between patients and providers, as well as the need for additional researc...
Hematological malignancies are a major global health challenge, with the US and China experiencing distinct epidemiological patterns. The study reveals that NHL is the most common type globally and in the US, while leukemia leads in incidence in China.
A phase 3 clinical trial found romiplostim significantly reduced chemotherapy dose delays and improved platelet counts in patients with gastrointestinal cancers who developed persistent low platelet counts during treatment. The therapy enables patients to maintain chemotherapy intensity, potentially preserving the integrity of cancer c...
A study by Yale School of Medicine found that 60% of physicians who treat sickle cell disease reported burnout, compared to 43% of those who do not. The data also showed that less job pride and less recreation time were associated with increased burnout.
A large venous thrombosis trial has found that apixaban is safer than rivaroxaban, with 3.3% of participants experiencing clinically relevant bleeding compared to 7.1% with rivaroxaban. This trial has significant implications for clinical practice and patient care.
A large registry study identifies a specific genetic mismatch linked to severe acute graft-versus-host disease (aGVHD) after cord blood transplantation, tripling the risk of life-threatening complications. Researchers found that a particular HLA combination in donors and recipients increased aGVHD risk by threefold.
A nationwide study found that periods can trigger severe pain in many women and girls with sickle cell disease, leading to emergency department visits and hospitalizations. The study's authors recommend a routine menstrual history screening as part of annual sickle cell care and connecting patients with reproductive health specialists.
A group of nerve cells in the brainstem has been identified as a stabilizing system for blood pressure, preventing fluctuations between daily activities. The study suggests that loss or dysfunction of these cells can lead to unstable blood pressure and is associated with conditions such as multiple system atrophy.
A study found that ultra-endurance running damages red blood cells, reducing their ability to carry oxygen and nutrients. The damage accelerates the aging and breakdown of these cells, with longer races leading to greater damage.
The National Comprehensive Cancer Network has published new guidelines for Pediatric Soft Tissue Sarcomas, highlighting the unique characteristics of this childhood cancer. The guidelines focus on rhabdomyosarcoma (RMS), a subtype with varying genetic changes that influence treatment outcomes.
The American Society of Hematology released guidelines for frontline and relapsed/refractory management of acute lymphoblastic leukemia (ALL) in adolescents and young adults (AYAs), outlining optimal approaches to treating high-risk patient populations. The guidelines highlight the need for additional research on immunotherapies and tr...
Researchers have developed an open-source pressure myography tool, HemoLens, which reduces the cost of vascular research to $750 from $40,000. The tool uses affordable manufacturing processes and customizable components, making it easier for researchers to study vascular function.
The American Society of Hematology released guidelines on the diagnosis of light chain (AL) amyloidosis, a rare and life-threatening disease of the bone marrow. The guidelines outline best practices for diagnosing the disorder, which typically takes about three years to diagnose.
A study published in EBioMedicine found changes in blood samples from almost 1,000 people hospitalized for COVID-19 may pinpoint patients at risk of long-term lung disease. The study identified elevated levels of certain molecules, which could lead to the development of simple blood tests to detect ongoing lung problems.
Researchers identify circulating extracellular vesicles produced in diseased kidneys as the culprit behind toxicity in the heart. The discovery could lead to the development of a blood test to identify patients at high risk for serious heart problems and novel treatments to prevent and treat heart failure.
A single dose of IV iron dextran is the most cost-effective treatment option for women with heavy menstrual bleeding and iron deficiency anemia. The study found that IV iron dextran improves quality of life and reduces costs compared to oral ferrous sulfate.
Researchers at Kanazawa University have developed a new combination therapy that combines CAR-T cell therapy with a SUMOylation inhibitor, which effectively suppresses MYC activity and slows the growth of Burkitt's lymphoma cells. The approach extends survival rates in mouse models by up to 80%.
Chromatin accessibility maps reveal that MDS stem cells gradually lose their normal identity and acquire characteristics typical of myeloid progenitors. A 'progenitor score' developed by the team tracks cell movement toward a progenitor-like state, correlating with disease severity and prognosis.
NEJM Clinician curates highly relevant clinical insights from over 150 peer-reviewed journals to give physicians clear guidance without the noise. The weekly publication delivers summaries and commentary in a concise, 30-minute read, helping healthcare providers stay informed and confident in their decisions.
Researchers present phase 1 study results of rapcabtagene autoleucel, a rapid CAR-T cell manufacturing platform that reduced production time to under two days. The treatment showed a manageable safety profile and promising antitumor activity, with complete remission rates ranging from 70% to 100% in patients.
Researchers at the University of Cincinnati present a new BTK degrader called Bexobrutideg, showing an 83% overall response rate in relapsed CLL patients. The treatment also shows efficacy in patients with CNS involvement and those with BTK mutations that none of currently approved BTK inhibitors are effective against.